|
|
|
|
Three Months Ended |
|
Year Ended |
|
|
|
|
November
1, |
|
November
2, |
|
November
1, |
|
November
2, |
|
|
|
|
2009 |
|
2008 |
|
2009 |
|
2008 |
| Reconciliation of GAAP to Pro Forma Net
Loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GAAP
net income (loss) |
|
$
|
1,241 |
|
|
$ |
235 |
|
$ |
(41,910 |
) |
|
$ |
(210,765 |
) |
| |
(a) |
Consolidation and restructuring charges, net of tax |
|
|
626 |
|
|
|
367 |
|
|
12,913 |
|
|
|
367 |
|
|
(b) |
Gain on sale of building, net of tax |
|
|
(1,474 |
) |
|
|
- |
|
|
(1,474 |
) |
|
|
- |
|
|
(c) |
Deferred financing fees net
of interest savings, net of tax |
|
|
2,942 |
|
|
|
- |
|
|
2,942 |
|
|
|
- |
|
|
(d) |
Warrant mark-to-market (gains)/charges, net of tax |
|
|
(6,544 |
) |
|
|
- |
|
|
304 |
|
|
|
- |
|
|
(e) |
Primarily goodwill and long-lived assets impairment, net of
tax |
|
|
- |
|
|
|
- |
|
|
1,050 |
|
|
|
199,177 |
|
| Pro
forma net income (loss) |
|
$ |
(3,209 |
) |
|
$ |
602 |
|
$ |
(26,175 |
) |
|
$ |
(11,221 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Year Ended |
|
|
|
|
November
1, |
|
November
2, |
|
November
1, |
|
November
2, |
|
|
|
|
2009 |
|
2008 |
|
2009 |
|
2008 |
| Reconciliation of GAAP Pro Forma Net
Income/Loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Applicable to Common
Shareholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GAAP
weighted average number of diluted shares outstanding |
|
|
48,907 |
|
|
|
41,996 |
|
|
43,210 |
|
|
|
41,658 |
|
|
|
(f) |
Adjustment to exclude equivalent shares issued
September
16, 2009 |
|
|
(5,603 |
) |
|
|
- |
|
|
(1,401 |
) |
|
|
- |
|
| Pro
forma weighted average number of diluted shares outstanding |
|
|
43,304 |
|
|
|
41,996 |
|
|
41,809 |
|
|
|
41,658 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) per diluted share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP |
|
$ |
(0.11 |
) |
|
$ |
0.01 |
|
$ |
(0.97 |
) |
|
$ |
(5.06 |
) |
|
Pro forma |
|
$ |
(0.07 |
) |
|
$ |
0.01 |
|
$ |
(0.63 |
) |
|
$ |
(0.27 |
) |
|
(a) |
|
Includes charges
related to announced restructurings in China and United
Kingdom. |
|
|
|
(b) |
|
Represents net gain
recognized on sale of Manchester, United Kingdom facility. |
|
|
| |
(c) |
|
Represents write-off
of deferred financing fees of $3.7 million recorded in interest expense as
a result of reduced debt offset by $0.8 million of reduced interest
expense resulting from the $98 million debt repayment with the proceeds of
the common stock and senior unsecured debt issuance. |
|
|
|
(d) |
|
Represents market
value impact of outstanding warrants and the clawback of 1.2 million
warrants ($6.0 million) both of which are recorded in other
income. |
|
|
|
(e) |
|
Represents goodwill
and long-lived assets impairment charge, net of tax |
|
|
|
(f) |
|
Adjustment to reflect
the excluded impact on weighted average shares outstanding during quarter
and year of the equivalent shares issued on September 16,
2009. |
